Your browser doesn't support javascript.
loading
[Retrospective analysis on 77 cases of T4b hypopharyngeal carcinoma treated by non-surgical treatments].
Gu, X; Liu, K; Gou, H C; Chen, N X; Zhang, X X.
Afiliação
  • Gu X; College of Otolaryngology Head and Neck Surgery, Chinese People's Liberation Army General Hospital, National Clinical Research Center for Otolaryngologic Diseases, Beijing 100853, China.
  • Liu K; College of Otolaryngology Head and Neck Surgery, Chinese People's Liberation Army General Hospital, National Clinical Research Center for Otolaryngologic Diseases, Beijing 100853, China.
  • Gou HC; College of Otolaryngology Head and Neck Surgery, Chinese People's Liberation Army General Hospital, National Clinical Research Center for Otolaryngologic Diseases, Beijing 100853, China.
  • Chen NX; College of Otolaryngology Head and Neck Surgery, Chinese People's Liberation Army General Hospital, National Clinical Research Center for Otolaryngologic Diseases, Beijing 100853, China.
  • Zhang XX; College of Otolaryngology Head and Neck Surgery, Chinese People's Liberation Army General Hospital, National Clinical Research Center for Otolaryngologic Diseases, Beijing 100853, China.
Article em Zh | MEDLINE | ID: mdl-35090205

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Neoplasias Hipofaríngeas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: Zh Revista: Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Neoplasias Hipofaríngeas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: Zh Revista: Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China